UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
19.91
-0.55 (-2.69%)
At close: Mar 9, 2026, 4:00 PM EDT
19.80
-0.11 (-0.55%)
After-hours: Mar 9, 2026, 5:11 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $969.26 million as of March 9, 2026. Its market cap has increased by 114.44% in one year.
Market Cap
969.26M
Enterprise Value
951.15M
1-Year Change
114.44%
Ranking
Category
Stock Price
$19.91
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $969.26M, an increase of 432.86%. That is a compound annual growth rate of 20.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 996.00M | -9.15% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 1.06B |
| AbCellera Biologics | 1.05B |
| ArriVent BioPharma | 1.04B |
| Inhibrx Biosciences | 1.01B |
| Xeris Biopharma Holdings | 1.00B |
| Compass Therapeutics | 992.28M |
| GH Research | 988.13M |
| Aktis Oncology | 987.94M |